RBM8A 抗体 (AA 72-152)
Quick Overview for RBM8A 抗体 (AA 72-152) (ABIN7571220)
抗原
See all RBM8A 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 72-152
- 
                                            原理
- Anti-Human RBM8A Polyclonal Antibody
- 
                                            纯化方法
- Antigen affinity purification.
- 
                                            免疫原
- E. coli - derived recombinant Human RBM8A (Gly72-Arg152).
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C,-20 °C,-80 °C
- 
                                            储存方法
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
 
- 
                                            
- 
    - RBM8A (RNA Binding Motif Protein 8A (RBM8A))
- 
                                            别名
- RBM8A
- 
                                            背景
- Ribonucleoprotein RBM8A, RNA-binding protein Y14, RNA-binding motif protein 8A, BOV-1, RBM8A, Binder of OVCA1-1, RBM8, RNA-binding protein 8A
- 
                                            UniProt
- Q9Y5S9
 抗原
- 
                    
 
                                     
                                     
                                    